BVS
Bioventus Inc
NASDAQ: BVS · HEALTHCARE · MEDICAL DEVICES
$10.14
+3.91% today
Updated 2026-06-05
Market cap
$589.41M
P/E ratio
21.22
P/S ratio
1.02x
EPS (TTM)
$0.41
Dividend yield
—
52W range
$6 – $11
Volume
0.6M
Bioventus Inc (BVS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$10.14
12-Month target
$9.16
2030 Target
$13.31
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.5B | $0.5B | $0.6B | $0.6B | $0.6B | $0.7B | $0.8B | $0.9B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 12.08% (capped 20%) · P/E: 21.22x (capped 25x) · Margin: 4.94%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.